題 名 |
Ledipasvir/Sofosbuvir for HCV Genotype 1, 2, 4-6 Infection: Real-world Evidence from a Nationwide Registry in Taiwan
|
作 者 |
Lo, Ching-chu;
Huang, Chung-feng;
Cheng, Pin-nan;
Tseng, Kuo-chih;
Chen, Chi-yi;
Kuo, Hsing-tao;
Huang, Yi-hsiang;
Tai, Chi-ming;
Peng, Cheng-yuan;
Bair, Ming-jong;
Chen, Chien-hung;
Yeh, Ming-lun;
Lin, Chih-lang;
Lin, Chun-yen;
Lee, Pei-lun;
Chong, Lee-won;
Hung, Chao-hung;
Chang, Te Sheng;
Huang, Jee-fu;
Yang, Chi-chieh;
Hu, Jui-ting;
Lin, Chih-wen;
Chen, Chun-ting;
Wang, Chia-chi;
Su, Wei-wen;
Hsieh, Tsai-yuan;
Lin, Chih-lin;
Tsai, Wei-lun;
Lee, Tzong-hsi;
Chen, Guei-ying;
Wang, Szu-jen;
Chang, Chun-chao;
Mo, Lein-ray;
Yang, Sheng-shun;
Wu, Wen-chih;
Huang, Chia-sheng;
Hsiung, Chou-kwok;
Kao, Chien-neng;
Tsai, Pei-chien;
Liu, Chen-hua;
Lee, Mei-hsuan;
Liu, Chun-jen;
Dai, Chia-yen;
Chuang, Wan-long;
Lin, Han-chieh;
Kao, Jia-horng;
Yu, Ming-lung;
|
書刊名 |
Journal of the Formosan Medical Association |
卷 期 |
121:8 2022.08[民111.08]
|
頁 次 |
頁1567-1578 |
分類號 |
415.5332 |
關鍵詞 |
Direct-acting antiviral;
Hepatitis C virus;
Ledipasvir;
Real-world;
Sofosbuvir;
|
語 文 |
英文(English) |